Bookmark and Share


Federal Register Summary for week of 19 October

    Commerce

  • Atlantic Highly Migratory Species; Advisory Panel

    AGENCY: National Marine Fisheries Service (NMFS), National Oceanic and Atmospheric Administration (NOAA), Commerce.

    ACTION: Notice; solicitation of nominations.


    SUMMARY: NMFS solicits nominations for the Atlantic Highly Migratory Species (HMS) Advisory Panel (AP). NMFS consults with and considers the comments and views of the HMS AP when preparing and implementing Fishery Management Plans (FMPs) or FMP amendments for Atlantic tunas, swordfish, sharks, and billfish. Nominations are being sought to fill approximately one-third (10) of the seats on the HMS AP for a 3-year appointment. Individuals with definable interests in the recreational and commercial fishing and related industries, environmental community, academia, and non-governmental organizations are considered for membership in the HMS AP (note that there are no Environmental/NGO terms expiring, so no nominations for that sector will be considered at this time).

    DATES: Nominations must be received on or before November 19, 2012.

    ADDRESSES: You may submit nominations and requests for the Advisory Panel Statement of Organization, Practices, and Procedures by any of the following methods:

    Email: HMSAP.Nominations@noaa.gov. Include in the subject line the following identifier: "HMS AP Nominations.''

    Mail: Jenni Wallace, Highly Migratory Species Management Division, NMFS, 1315 East-West Highway, Silver Spring, MD 20910.

    Fax: 301-713-1917.

    FOR FURTHER INFORMATION CONTACT: Jenni Wallace at (301) 427-8503.

    http://www.gpo.gov/fdsys/pkg/FR-2012-10-19/html/2012-25708.htm

  • Proposed Information Collection; Comment Request; Coastal Ocean Program Grants Proposal Application Package

    AGENCY: National Oceanic and Atmospheric Administration (NOAA), Commerce.

    ACTION: Notice.


    SUMMARY: The Department of Commerce, as part of its continuing effort to reduce paperwork and respondent burden, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995.

    DATES: Written comments must be submitted on or before December 17, 2012.

    ADDRESSES: Direct all written comments to Jennifer Jessup, Departmental Paperwork Clearance Officer, Department of Commerce, Room 6616, 14th and Constitution Avenue NW., Washington, DC 20230 (or via the Internet at JJessup@doc.gov).

    FOR FURTHER INFORMATION CONTACT: Requests for additional information or copies of the information collection instrument and instructions should be directed to Laurie Golden, 301-713-3338 ext 151 or laurie.golden@noaa.gov.

    http://www.gpo.gov/fdsys/pkg/FR-2012-10-16/html/2012-25354.htm

  • Proposed Information Collection; Comment Request; Evaluations of Coastal Zone Management Act Programs--State Coastal Management Programs and National Estuarine Research Reserves

    AGENCY: National Oceanic and Atmospheric Administration (NOAA), Commerce.

    ACTION: Notice.


    SUMMARY: The Department of Commerce, as part of its continuing effort to reduce paperwork and respondent burden, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995.

    DATES: Written comments must be submitted on or before December 14, 2012.

    ADDRESSES: Direct all written comments to Jennifer Jessup, Departmental Paperwork Clearance Officer, Department of Commerce, Room 6616, 14th and Constitution Avenue NW., Washington, DC 20230 (or via the Internet at JJessup@doc.gov).

    FOR FURTHER INFORMATION CONTACT: Requests for additional information or copies of the information collection instrument and instructions should be directed to L. Christine McCay, (301) 563-1163 or chris.mccay@noaa.gov.

    http://www.gpo.gov/fdsys/pkg/FR-2012-10-15/html/2012-25226.htm

  • Environmental Protection Agency

  • Notification of a Public Teleconference of the Clean Air Scientific Advisory Committee (CASAC) Ozone Review Panel

    AGENCY: Environmental Protection Agency (EPA).

    ACTION: Notice.


    SUMMARY: The EPA Science Advisory Board (SAB) Staff Office announces a public teleconference of the CASAC Ozone Review Panel to discuss its draft reviews of four EPA documents: Integrated Science Assessment for Ozone and Related Photochemical Oxidants (Third External Review Draft-- June 2012), Health Risk and Exposure Assessment for Ozone (First External Review Draft--Updated August 2012), Welfare Risk and Exposure Assessment for Ozone (First External Review Draft--Updated August 2012), and Policy Assessment for the Review of the Ozone National Ambient Air Quality Standards (First External Review Draft--August 2012).

    DATES: The CASAC Ozone Review Panel teleconference will be held on Monday, November 5, 2012, from 9:00 a.m. to 1:00 p.m. (Eastern Time).

    ADDRESSES: The public teleconference will take place by telephone only.

    FOR FURTHER INFORMATION CONTACT: Any member of the public who wants further information concerning the public teleconference may contact Dr. Holly Stallworth, Designated Federal Officer (DFO), via telephone at (202) 564-2073 or email at stallworth.holly@epa.gov. General information concerning the CASAC can be found on the EPA Web site at http://www.epa.gov/casac.

    http://www.gpo.gov/fdsys/pkg/FR-2012-10-19/html/2012-25791.htm

  • Notification of a Public Teleconference of the Science Advisory Board; Perchlorate Advisory Panel

    AGENCY: Environmental Protection Agency (EPA).

    ACTION: Notice.


    SUMMARY: The Environmental Protection Agency (EPA) Science Advisory Board (SAB) Staff Office announces two public teleconferences of the SAB Perchlorate Advisory Panel to discuss its revised draft report concerning EPA's draft white paper Life Stage Considerations and Interpretation of Recent Epidemiological Evidence to Develop a Maximum Contaminant Level Goal (MCLG) for Perchlorate.

    DATES: The public teleconferences will be held on Wednesday December 5, 2012 and Friday December 7, 2012. The teleconferences will be held from 2:00 p.m. to 5:00 p.m. (Eastern Standard Time) on both days.

    ADDRESSES: The teleconference will be conducted by telephone only.

    FOR FURTHER INFORMATION CONTACT: Any member of the public who wants further information concerning the meeting may contact Mr. Thomas Carpenter, Designated Federal Officer (DFO), EPA Science Advisory Board (1400R), U.S. Environmental Protection Agency, 1300 Pennsylvania Avenue NW., Washington, DC 20460; via telephone/voice mail (202) 564-4885; fax (202) 565-2098; or email at carpenter.thomas@epa.gov. General information concerning the SAB can be found on the SAB Web site at http://www.epa.gov/sab.

    http://www.gpo.gov/fdsys/pkg/FR-2012-10-19/html/2012-25793.htm

  • Health and Human Services

  • Cellular, Tissue and Gene Therapies Advisory Committee; Notice of Meeting

    AGENCY: Food and Drug Administration, HHS.

    ACTION: Notice.


    This notice announces a forthcoming teleconference meeting of a public advisory committee of the Food and Drug Administration (FDA). At least one portion of the meeting will be closed to the public.

    Name of Committee: Cellular, Tissue and Gene Therapies Advisory Committee.

    General Function of the Committee: To provide advice and recommendations to the Agency on FDA's regulatory issues.

    DATES: Date and Time: The teleconference meeting will be held on November 29, 2012 from 1 p.m. to 5 p.m., Eastern Time.

    Location: National Institutes of Health (NIH), Building 29A, Conference Room 1A09, 9000 Rockville Pike, Bethesda, MD 20892. The public is welcome to attend the meeting at the specified location where a speakerphone will be provided. Public participation in the meeting is limited to the use of the speakerphone in the conference room. Important information about transportation and directions to the NIH campus, parking, and security procedures is available on the internet at http://www.nih.gov/about/visitor/index.htm. (FDA has verified the Web site address, but FDA is not responsible for any subsequent changes to the Web site after this document publishes in the Federal Register.) Visitors must show two forms of identification, one of which must be a government-issued photo identification such as a Federal employee badge, driver's license, passport, green card, etc. Detailed information about security procedures is located at http://www.nih.gov/about/visitorsecurity.htm. Due to the limited available parking, visitors are encouraged to use public transportation.

    Contact Person: Gail Dapolito or Sheryl Clark, Center for Biologics Evaluation and Research (HFM-71), Food and Drug Administration, 1401 Rockville Pike, Rockville MD 20852, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area). A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the Agency's Web site at http://www.fda.gov/AdvisoryCommittees/default.htm and scroll down to the appropriate advisory committee meeting link, or call the advisory committee information line to learn about possible modifications before coming to the meeting.

    Agenda: On November 29, 2012 the committee will meet in open session to hear updates of research programs in the Gene Transfer and Immunogenicity Branch, Office of Cellular, Tissue and Gene Therapies, Center for Biologics Evaluation and Research, and the Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research, FDA.

    FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA's Web site after the meeting. Background material is available at http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm. Scroll down to the appropriate advisory committee link.

    Procedure: On November 29, 2012, from 1 p.m. to 4 p.m. (Eastern Time) the meeting is open to the public. Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person on or before November 21, 2012. Oral presentations from the public will be scheduled between approximately 3 p.m. and 4 p.m. Those individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before November 14, 2012. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by November 15, 2012.

    Closed Committee Deliberations: On November 29, 2012, from 4 p.m. to 5 p.m., the meeting will be closed to permit discussion where disclosure would constitute a clearly unwarranted invasion of personal privacy (5 U.S.C. 552b(c)(6)). The committee will discuss reports of intramural research programs and make recommendations regarding personnel staffing decisions.

    Persons attending FDA's advisory committee meetings are advised that the Agency is not responsible for providing access to electrical outlets.

    FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Gail Dapolito at least 7 days in advance of the meeting.

    FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm for procedures on public conduct during advisory committee meetings. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2).

    http://www.gpo.gov/fdsys/pkg/FR-2012-10-17/html/2012-25482.htm

back to Federal Register Resource

Bookmark and Share